Meeting

Winter Rheumatology Symposium

Date:

To Be Announced

Location:

Snowmass, CO

Program Information

CME: TBA    MOC: TBA

The Winter Rheumatology Symposium will provide the most up-to-date, practical clinical information on the diagnosis and management of patients with rheumatic and immune disorders.

For information about the 2023 meeting, see the Winter Rheumatology Symposium 2023 section below.

Registration Fees

To be announced

Syllabi

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this live activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. The Winter Rheumatology Symposium is independently planned by the Winter Rheumatology Symposium Planning Committee under the direction of the ACR Committee on Education.

Maintenance of Certification
After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points display in the portal.

MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABIM CME MOC Certified

Faculty and Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker's bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

View ACR's ACCME disclosure practices

2024 disclosures coming soon

Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives. See current supporters, guidelines, and benefits of supporting the ACR.

COVID-19 Policies

The ACR no longer requires proof of prior vaccination, periodic testing, masking, or observance of social distancing to participate in meetings. We applaud individuals' efforts to prevent the spread of infectious agents. We request that individuals with symptoms or known infections stay home and not participate in face-to-face ACR gatherings. The ACR will comply with local, state, federal regulations and acknowledges that this policy is subject to change.

2023 Winter Rheumatology Symposium

CME: 24.00    MOC: 24.00

CME and MOC credit must be claimed by January 21, 2024, at 11:59 PM ET.

Target Audience
This course is designed for rheumatologists, physicians, and other health care providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of patients with rheumatic and immunologic diseases
  • Describe the most current information regarding the pathophysiology underlying rheumatic disorders

The ACR thanks Amgen, Inc. and UCB, Inc. for independent medical education grant support of the Winter Rheumatology Symposium 2023.

Contact Info / Inquiries

American College of Rheumatology
education@rheumatology.org
404-633-3777, ext. 381

Registration Support Center
800-636-4766 (US & Canada)
415-979-2265 (International)
Fax: 415-293-5231

© 2023 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us